Nitroglycerin and study drug for coronary artery disease
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether a new drug called nurandociguat, when taken with nitroglycerin, is safe and how it affects the body in people with coronary artery disease. It may help improve treatment options for this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You have coronary artery disease, confirmed by a heart test (like an angiogram) or a past heart attack more than 6 months ago.
- Your kidney function is at a certain level (eGFR of 30 or higher).
- You weigh at least 60 kg (about 132 lbs) and your body mass index is between 18 and 36.
- You do not have severe heart failure, recent heart procedures, or certain heart rhythm problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of testing the small blood vessels in the heart to understand chest pain when no major blockages are found. It may help doctors learn more about why you have chest pain and how to treat it.
This study tests whether giving a drug called nicorandil directly into the heart artery just before placing a stent can help keep blood flow normal and reduce complications after the procedure.
This study tests whether taking an inorganic nitrate supplement can improve chest pain and blood flow in women who have chest pain but no blocked heart arteries. It may help if your heart's small blood vessels are not working properly.
This trial tests a special balloon coated with medicine to treat blocked small arteries in the heart. It may help people who have new blockages and are getting a procedure to open those arteries.
This trial tests whether a medicine called nicorandil can improve blood flow in small heart blood vessels after a heart attack, when given during the procedure to open the blocked artery. If you qualify, you may receive this extra treatment to help your heart recover better.
This trial tests a new medicine called UDP-003 in two groups: healthy volunteers and people who had a heart event (acute coronary syndrome) at least a year ago. The goal is to see if the drug is safe and how the body handles it, which could lead to better treatments for heart disease.
Hear when a new Stable Coronary Artery Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.